Evidence map›Paper›PMID 25622053›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2015

Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.

Albert M Anderson, Jaroslaw Harezlak, Ajay Bharti, Deming Mi, Michael J Taylor, Eric S Daar, Giovanni Schifitto, Jianhui Zhong, Jeffry R Alger, Mark S Brown and 9 more

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. MR spectroscopy and diffusion imaging in people with human immunodeficiency virus: Relationships to clinical and immunologic findings.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 1 country.

Albert M Anderson*Emory University, Atlanta, GA; †Indiana University, Indianapolis, IN; ‡University of California, San Diego, San Diego, CA; §University of California, Los Angeles, CA; ‖University of Rochester School of Medicine, Rochester, NY; ¶University of Colorado Medical Center, Denver, CO; #University of Pittsburgh, Pittsburgh, PA; **University of Hawaii, Honolulu, HI; ††University of Florida, Gainesville, FL; and ‡‡Tufts University School of Medicine, Boston, MA.
Jaroslaw Harezlak
Ajay Bharti
Deming Mi
Michael J Taylor
Eric S Daar
Giovanni Schifitto
Jianhui Zhong
Jeffry R Alger
Mark S Brown
Elyse J Singer
Thomas B Campbell
Deborah D McMahon
Steven Buchthal
Ronald Cohen
Constantin Yiannoutsos
Scott L Letendre
Bradford A Navia
HIV Neuroimaging Consortium
Indiana University – Purdue University Indianapolis · USUniversity of California, Los Angeles · USUniversity of California, San Diego · USUniversity of Colorado Boulder · USUniversity of Rochester · USEmory University · USTufts University · USUniversity of Florida · USUniversity of Hawaii System · USUniversity of Pittsburgh · US

Funding

LOC: HIV Vaccine Trials NetworkUM1AI068614 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Dan H. Barouch, Lawrence Corey · 2011 to 2026
$1175.6M
Leadership Group for a Global HIV Vaccine Clinical Trials NetworkU01AI068614 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI COREY, LAWRENCE · 2006 to 2010
$181.5M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
UCSD Department of Medicine HIV/AIDS Clinical Trials UnitUM1AI069432 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TIMOTHY J. WILKIN · 2012 to 2026
$50.4M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
University of Florida Older Americans Independence Center (OAIC)P30AG028740 · NIA · UNIVERSITY OF FLORIDA · PI Peihua Qiu · 2007 to 2026
$22.8M
Virology CoreP01AA019072 · NIAAA · BROWN UNIVERSITY · PI KAHLER, CHRISTOPHER W. · 2010 to 2024
$19.7M
UCSD Department of Medicine HIV/AIDS Clinical Trials UnitU01AI069432 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BENSON, CONSTANCE ANN · 2007 to 2011
$19.3M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
PROTON MRS STUDIES OF CEREBRAL INJURY IN HIV INFECTIONR01NS036524 · NINDS · TUFTS UNIVERSITY BOSTON · PI NAVIA, BRADFORD · 1997 to 2009
$12.9M
FIC NIH HHS R24 TW008881FIC NIH HHS TW008881NCATS NIH HHS UL1 TR001082NCI NIH HHS CA172050NCI NIH HHS R01 CA172050NCRR NIH HHS RR025780NCRR NIH HHS UL1 RR025780NHLBI NIH HHS HL098996NHLBI NIH HHS HL121816NHLBI NIH HHS U01 HL098996NHLBI NIH HHS U01 HL121816NIAAA NIH HHS K99 AA020235NIAAA NIH HHS P01 AA019072NIAID NIH HHS AI068614NIAID NIH HHS AI069432NIAID NIH HHS P30 AI042853NIAID NIH HHS U01 AI069432NIAID NIH HHS UM1 AI068614NIAID NIH HHS UM1 AI069432NIA NIH HHS P30 AG028740NIDDK NIH HHS R01 DK089070NIMH NIH HHS K23 MH085512NIMH NIH HHS K23 MH095679NIMH NIH HHS K24 MH097673NIMH NIH HHS MH092225NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH074368NIMH NIH HHS R01 MH092225NIMH NIH HHS R01 MH099921NIMH NIH HHS U01 MH083500NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100929NINDS NIH HHS R01 NS036524NINDS NIH HHS R01 NS080655NINDS NIH HHS R01 NS36524
6 · The paper itself

Abstract

objectivesHIV-associated brain injury persists despite combination antiretroviral therapy, but contributing factors remain poorly understood. We postulated that inflammation-associated biomarkers will be associated with cerebral injury on proton magnetic resonance spectroscopy in chronically HIV-infected subjects.

methodsFive biomarkers were measured in 197 HIV-infected subjects: soluble CD14, MCP-1, IP-10, MIP-1β, and fractalkine. Levels of N-acetyl aspartate (NAA), Choline (Cho), Myoinositol (MI), Glutamate + Glutamine (Glx), and Creatine (Cr) were acquired in the midfrontal cortex (MFC), frontal white matter, and basal ganglia (BG). Predictive models were built through linear regression, and the best models were chosen using the Akaike Information Criterion.

resultsIncreases in plasma or CSF MCP-1 were associated with lower NAA/Cr in the MFC and BG, whereas metabolite changes in the frontal white matter for NAA/Cr, GlxCr, and Cho/Cr were explained almost exclusively by a single factor, sCD14. Plasma and CSF levels of this factor were also significantly associated with Glx/Cr in MFC and BG. Higher CSF FKN was associated with higher NAA/Cr in BG. Best predictors for higher Cho/Cr in BG and MFC were CSF sCD14 and CSF MIP-1β. Plasma and CSF IP-10 were only associated with Cho/Cr in MFC. Of the 3 models that simultaneously accounted for both plasma and CSF, there were more associations between CSF biomarkers and magnetic resonance spectroscopy metabolites.

conclusionsMarkers of inflammation and immune activation, in particular MCP-1 and sCD14, predominantly reflecting CNS sources, contribute to the persistence of brain injury in a metabolite and region-dependent manner in chronically HIV-infected patients on stable combination antiretroviral therapy.

Indexed as

AdultAIDS Dementia ComplexAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveBiomarkersBrainCerebrospinal FluidCohort StudiesCross-Sectional StudiesFemaleHIV InfectionsHumansMaleMiddle AgedPlasmaAnti-Retroviral AgentsBiomarkers

Identifiers

PMID25622053
PMCPMC4424074
OpenAlexW2325077524

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.